High Translatable DIO Rodent Model: Accelerating Weight Loss Drug Discovery

Obesity remains a critical global health threat, affecting over one billion people worldwide and exacerbating risks for type 2 diabetes, cardiovascular diseases, and fatty liver disease. The pharmaceutical landscape is witnessing rapid transformation through novel oral GLP-1 agents, long-acting injectables, and multi-target therapies that are redefining treatment possibilities.

At the preclinical stage, BioDuro’s Diet-Induced Obesity (DIO) rodent models, enhanced with high-resolution phenotyping tools, create a crucial translational bridge to accelerate weight loss drug development.